Chordate Medical Holding AB (publ)

OM:CMH Stock Report

Market Cap: SEK 8.8m

Chordate Medical Holding Past Earnings Performance

Past criteria checks 0/6

Chordate Medical Holding's earnings have been declining at an average annual rate of -6.2%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been declining at an average rate of 16.2% per year.

Key information

-6.2%

Earnings growth rate

54.3%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate-16.2%
Return on equity-190.5%
Net Margin-949.7%
Next Earnings Update28 Mar 2025

Recent past performance updates

Recent updates

We Think Chordate Medical Holding (NGM:CMH) Needs To Drive Business Growth Carefully

May 20
We Think Chordate Medical Holding (NGM:CMH) Needs To Drive Business Growth Carefully

Revenue & Expenses Breakdown

How Chordate Medical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:CMH Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243-29290
30 Jun 243-28280
31 Mar 242-28280
31 Dec 232-29280
30 Sep 231-28270
30 Jun 231-29270
31 Mar 230-28250
31 Dec 220-28260
30 Sep 220-27250
30 Jun 221-24230
31 Mar 222-23240
31 Dec 212-22230
30 Sep 213-20210
30 Jun 213-21210
31 Mar 213-20200
31 Dec 204-20190
30 Sep 204-20200
30 Jun 204-22210
31 Mar 204-24220
31 Dec 193-25210
30 Sep 191-26190
30 Jun 191-26190
31 Mar 191-26190
31 Dec 181-27190
30 Sep 181-27260
30 Jun 181-27230
31 Mar 181-26200
31 Dec 171-23170
30 Sep 171-1670
31 Mar 170-1370
31 Dec 160-1460
31 Dec 151-1650

Quality Earnings: CMH is currently unprofitable.

Growing Profit Margin: CMH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CMH is unprofitable, and losses have increased over the past 5 years at a rate of 6.2% per year.

Accelerating Growth: Unable to compare CMH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CMH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: CMH has a negative Return on Equity (-190.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 21:28
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chordate Medical Holding AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution